The death toll from the pandemic climbed to 4,52,811 with the addition of 160 fatalities, showed the data updated at 8 am.
Officials said the study would have started earlier as it was planned to be conducted with the rapid antibody test kits brought from China.
The death toll climbed to 4,52,651 with 197 fresh fatalities, according to the data updated at 8 am.
The death toll climbed to 4,52,290 with 166 fresh fatalities, according to the data updated at 8 am.
The Central Drugs Standard Control Organisation has granted restricted emergency use authorisation to two new vaccines and a drug for COVID-19, taking the number of preventives and treatments available in India to 12.
The death toll climbed to 4,51,814 with 379 fresh fatalities, according to the data updated at 8 am.
This may include Rs 1,500 as a screening test for suspect cases and an additional Rs 3,000 for confirmation test, the guidelines said.
The daily rise in new coronavirus infections has been below 30,000 for 18 straight days.
With 21,257 people testing positive for the coronavirus infection in a day, India's total tally of cases rose to 3,39,15,569, while the number of active cases declined to 2,40,221, the lowest in 205 days, according to data updated by the Union health ministry on Friday.
The number of people who have recuperated from the disease surged to 2,75,04,126, while the case fatality rate has increased to 1.22 per cent, the data stated.
The government on Monday issued an advisory for rational use of Remdesivir in COVID-19 treatment, underlining that the anti-viral drug must be advised by senior faculty members directly involved in the patient's care.
India reported 1,20,529 fresh COVID-19 cases, the lowest single-day rise in infections in around two months, taking the infection tally to 2,86,94,879, according to the Union health ministry data.
Cumulatively, these five states reported 536 deaths in a day which is over 65 per cent of the total fatalities registered in the country during the period. India reported 69,921 new instances of coronavirus infection in 24 hours taking the country's tally of cases to 36,91,166.
Of the 3,071 cases of Omicron variant, 1,203 have recovered or migrated, according to the data updated by the ministry at 8 am.
3,007 fresh cases of Omicron reported across 27 states and UTs.
India reported 1,27,510 fresh COVID-19 cases, the lowest in 54 days, while the daily positivity rate dropped to 6.62 per cent, according to the Union Health Ministry data.
Anti-inflammatory or immunomodulatory therapy, such as steroids, can have the risk of secondary infection like invasive mucormycosis, when used too early, at higher dose or for longer than required, they highlighted.
India reported the lowest daily new coronavirus infections in 50 days with 1,52,734 cases, taking the tally to 2,80,47,534 on Monday, while the active caseload declined to 20,26,092, the health ministry said.
Of the 1,431 patients infected with the Omicron variant of the virus so far, 374 have either recuperated or migrated, according to the ministry's data updated at 8 am.
It also recorded 16,764 fresh COVID-19 cases and 220 more fatalities due to the viral disease.
These include the 25 cases which were announced till Thursday. "All the 29 persons are in physical isolation in health facilities," an official said.
Out of this, Maharashtra topped the list with 167 cases followed by Delhi with 165 cases, Kerala with 57 cases and Telangana has confirmed 55 cases.
'Antibodies remain in the blood for at least seven to nine months.'
As many as 422 Omicron cases have been detected across 17 states and Union Territories in India so far and 130 of these people have recovered or migrated, according to Union health ministry data updated on Sunday.
The death toll due to the disease has climbed to 4,43,928 with 431 daily fatalities being recorded, according to data updated by the ministry at 8 am.
Maharashtra has recorded a maximum of 108 Omicron cases, followed by Delhi at 79, Gujarat 43, Telangana 38, Kerala 37, Tamil Nadu 34 and Karnataka 31.
According to a study done by Singapore University of Technology and Design Data, coronavirus will 100 per cent end across the world on December 8.
The apex health research body on Tuesday validated the 1,000th testing laboratory, ramping up the capacity for detection of COVID-19 in the country. Currently, three lakh samples can be tested per day, an official said.
The death toll due to the disease has climbed to 4,42,874, with 219 daily fatalities being recorded, the data updated at 8 am showed.
Maharashtra has recorded the maximum 65 cases of the Omicron variant followed by Delhi at 64, Telangana 24, Karnataka 19, Rajasthan 21 and Kerala 15.
The institute expects to complete both, phase-2 and 3 trials in India by the end of this year.
The daily rise in new coronavirus infections has been recorded below 15,000 for the last 55 days now.
The company has set an affordable ceiling price of USD 3 (around Rs 225) per dose, it added.
This is the seventh consecutive day that COVID-19 cases have increased by more than 45,000.
The number of fresh cases of the coronavirus infection has been recorded below 15,000 for the last 47 days now.
In phase I, the vaccine would be tested on 375 volunteers and the maximum of 100 of them would be from AIIMS.
ICMR's serological survey, whose findings will be made public next week, suggests that the rate of contagion may be a lot higher in most-affected cities such as Delhi, Mumbai, and Pune.
Groundbreaking HIV researcher Dr Suniti Solomon, the first to bring to the world the prevalence of the infection in India in 1986 and one who successfully led research into the treatment of the deadly virus, passed away at her residence in Chennai on Tuesday.
The phase-three human clinical trial of indigenously developed anti-coronavirus vaccine candidate Covaxin began at the AIIMS in New Delhi on Thursday, with Dr M V Padma Srivastava, the chief of Neurosciences Centre at the premier institute, and three other volunteers receiving the first dose.
The ministry of civil aviation on Wednesday said only two per cent of the passengers coming from countries that are not in the 'at-risk' list will be subject to random sampling for coronavirus and such passengers will be permitted to leave the airport after giving the samples.
